Work

CD20xCD3 Bispecific Antibodies As Standard of Care (SOC) for Relapse/Refractory (R/R) Large B-Cell Lymphoma (LBCL) - a Multicenter Retrospective Study

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-203538

Authors: Ning Dong, Sushmita Khadka, Jose Sandoval-Sus, Carlos Silva Rondon, Ariel Perez, Tiba Al Sagheer, Madiha Iqbal, Juan Pablo Alderuccio, Cristian Rodriguez Arocho, Syeda Saba Kareem, Michael D. Jain, Julio C. Chavez

Institutions: Moffitt Cancer Center, Memorial Healthcare System, Baptist Health South Florida, Mayo Clinic in Florida, University of Miami, Sylvester Comprehensive Cancer Center, Auxilio Mutuo Hospital

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405041688

Cites:

Cited by: 1

Related to: 10